Fierce Pharma

MARCH 19, 2024

This year marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the company's red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nat | 2024 marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the Danish drugmaker’s red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nation.

Medicine 322

Medicine 322

MedCity News

MARCH 19, 2024

AstraZeneca’s Fusion Pharmaceuticals acquisition is the latest in a wave of M&A activity that includes recent deals by Eli Lilly and Bristol Myers Squibb. The lead Fusion program is in mid-stage clinical development for treating advanced prostate cancer.

Pharmaceutical 121

Pharmaceutical Leads Biopharma Pharma 121

Fierce Pharma

MARCH 19, 2024

After a year marked by Gilead's oncology push and an ongoing focus on CAR-T therapies, CEO Daniel O’Day collected his largest total compensation package since the year he arrived at the Califo | The CEO collected his highest total compensation package since his first year in the role in 2019.

255

255

Integrity Solutions

MARCH 19, 2024

As a sales leader have you looked at your forecast and asked questions like these: “Do we have enough opportunities in our forecast to confidently make our goal this quarter/year?” “We may have enough opportunities, but are they large enough in terms of projected revenue? What is our go-get?” “Are we progressing these opportunities through our pipeline process towards close?

Sales 108

Sales Sales pipeline Sales process Sales Strategy 108

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MARCH 19, 2024

Guiding AbbVie through an extraordinary decade-plus, riding the success of juggernaut inflammatory disease drug Humira and softening the landing upon its decline, Richard Gonzalez continues to reap | In his final full year as AbbVie’s CEO, Richard Gonzalez pulled down a compensation package worth $25.7 million, according to the company’s proxy filing.

254

254

European Pharmaceutical Review

MARCH 19, 2024

Under a new deal, Novartis has agreed to acquire US-based biopharma company IFM Therapeutics, for a total of up to $835 million. As part of this new agreement, Novartis has exercised its option to acquire all outstanding capital stock of IFM Due, a subsidiary company of IFM. Therefore, under the acquisition, Novartis has full rights to IFM Due’s portfolio of small molecule Stimulator of Interferon Genes (STING) antagonists, IFM confirmed.

Biopharma 105

Biopharma Medicine Patients Pharmaceutical 105

Pharmaceutical Commerce

MARCH 19, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.

Pharma 105

Pharma 105

Fierce Pharma

MARCH 19, 2024

After a two-year stint under Merck & Co. veteran Frank Clyburn, New York’s International Flavors & Fragrances (IFF) is stripping away a major component of its healthcare persona. | New York's IFF—which dabbles in food, beverage, beauty and pharmaceutical supply chains, among others—has agreed to sell its pharma solutions business to French plant-based ingredient maker Roquette for up to $2.85 billion.

Pharma 236

Pharma Food Healthcare Healthcare 236

MedCity News

MARCH 19, 2024

In order to effectively address the nursing shortage, hospitals must embrace three key products on the market that has been proven to alleviate nurse burnout, according to Syl Trepanier, chief nursing officer at Providence.

Marketing 108

Marketing 108

Fierce Pharma

MARCH 19, 2024

Twelve years after Takeda's Iclusig (ponatinib) earned a restricted FDA approval to treat certain patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), the U.S. | Twelve years after Takeda's Iclusig earned a restricted FDA approval to treat certain patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), the U.S. regulator has signed off on a wider use.

FDA 218

FDA Patients 218

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

MARCH 19, 2024

In addition to drug discovery deals, NVIDIA also announced partnerships with J&J MedTech and GE Healthcare for genAI in MedTech.

Healthcare 112

Healthcare Healthcare 112

Fierce Pharma

MARCH 19, 2024

Despite Translarna's troubled history at the FDA—and a recent regulatory stumble in Europe—PTC Therapeutics once again hopes to convince U.S. | Despite Translarna's troubled history at the FDA—and a recent regulatory stumble in Europe—PTC Therapeutics once again hopes to convince U.S. regulators of the value of its Duchenne muscular dystrophy therapy.

FDA 213

FDA 213

European Pharmaceutical Review

MARCH 19, 2024

According to research by InsightAce Analytic Pvt. Ltd., the global continuous bioprocessing market is expected to value $1,067.8 million by 2031. While the market was valued at $255.9 million in 2023, the report predicted it will witness a CAGR of 19.72 percent between 2024-2031. The research explained that companies are looking to reduce manufacturing costs and increase productivity, which is driving implementation of this type of bioprocessing.

Marketing 94

Marketing Manufacturing Pharmaceutical 94

Fierce Pharma

MARCH 19, 2024

Did Novartis break U.S. antitrust laws in the storied Eylea-Lucentis rivalry? Thanks to an appeals court ruling, Regeneron has another chance to lay out its argument. | Did Novartis break U.S. antitrust laws in the storied Eylea-Lucentis rivalry? Thanks to an appeals court ruling, Regeneron has another chance to lay out its argument.

144

144

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

MARCH 19, 2024

At the MedCity INVEST conference, scheduled for May 21-22 at the Ritz Carlton in Chicago, health benefits in the context of value-based care will be one of several topics of discussion at the boutique healthcare investment event. Register today!

Healthcare 102

Healthcare Healthcare 102

Fierce Pharma

MARCH 19, 2024

Just a few days ago, Madrigal Pharmaceuticals made history by winning FDA approval for its metabolic dysfunction-associated steatohepatitis (MASH) med Rezdiffra. | Madrigal's Rezdiffra became the first drug approved to treat metabolic dysfunction-associated steatohepatitis (MASH) just a few days ago. Now, the company looks to support the upcoming launch by selling shares.

Sales 130

Sales FDA Pharmaceutical 130

Pharmaceutical Technology

MARCH 19, 2024

The new initiative aims to spur innovation and mobilisation of sectors to drive women’s health research.

111

111

pharmaphorum

MARCH 19, 2024

AstraZeneca upgrades its radiopharma alliance with Fusion Pharma, opting to buy the biotech outright in a deal worth around $2 billion

Pharma 101

Pharma 101

Advertisement

Pharmaceutical Technology

MARCH 19, 2024

The US FDA has granted approval to Orchard Therapeutics' Lenmeldy for specific forms of metachromatic leukodystrophy (MLD).

FDA 98

FDA 98

PharmaVoice

MARCH 19, 2024

Curevo Vaccine is readying a phase 3 trial for a candidate it believes could have an edge over GSK’s blockbuster Shingrix.

Side effects 98

Side effects Marketing 98

pharmaphorum

MARCH 19, 2024

New phase 3 data sets up filings for Bayer's non-hormonal menopause symptom treatment elinzanetant and a challenge to Astellas’ first-to-market Veozah

Marketing 91

Marketing 91

MedCity News

MARCH 19, 2024

Do you advise self-insured employers? The 2023 Benefit Consultant Sentiment INDEX offered robust insights and cast a spotlight on the evolving roles of employers as they navigate the changing healthcare landscape. Your insights offer leading, innovative points of view that can guide employers and peers. Join us for this year’s survey!

Insurance 89

Insurance Consulting Healthcare Healthcare 89

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

pharmaphorum

MARCH 19, 2024

Johnson & Johnson has allied with NVIDIA to bring artificial intelligence into operating rooms and accelerate the adoption of digital tech in surgery

84

84

Eversana Intouch

MARCH 19, 2024

Every year, America celebrates and acknowledges the vital role of women in American history with a designated Women’s History Month in March. In recognizing the specific achievements women have made across the years, we also recognize those achievements didn’t come without challenges. And this month, we’re bringing to light the challenges in women’s healthcare that we can help solve and make history together.

Marketing 59

Marketing Healthcare Healthcare Prescription 59

pharmaphorum

MARCH 19, 2024

Johnson & Johnson has allied with NVIDIA to bring artificial intelligence into operating rooms and accelerate the adoption of digital tech in surgery

65

65

Pharmaceutical Technology

MARCH 19, 2024

Rising numbers of counterfeit drugs are entering pharmaceutical supply chains, necessitating advanced track-and-trace systems.

Pharmaceutical 64

Pharmaceutical 64

Advertisement

Distribution

Nixon Gwilt Law

MARCH 19, 2024

Watch leading AI attorneys Rebecca Gwilt, Reema Taneja, and Sam Pinson as they cover: How the federal government and the states are regulating AI tools and functions in digital health today Key areas of risk for digital health companies to audit and examine to de-risk their AI tools and services Fundamental principles for AI deployment to prepare digital health companies for compliance with impending regulatory changes in 2024/2025 You’ll walk away from this video with a better understanding of

Government 52

Government Leads 52

Clarify Health

MARCH 19, 2024

With soaring healthcare spending and poor health outcomes posing significant challenges, the healthcare industry is crying out for higher-value care. At the forefront of this revolution is the rising use of various types of healthcare provider data and deep analytics to assess provider performance and build cost-effective, quality networks. Health plans can utilize these resources to navigate the turbulent waters of healthcare cost and quality, ultimately enhancing overall outcomes.

Networking 52

Networking Healthcare Healthcare Healthcare Provider 52

Pharmaceutical Commerce

MARCH 19, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.

Patients 52

Patients Pharma 52

PM360

MARCH 19, 2024

Every year in March, the city known for keeping it weird turns it up a notch with the multi-audience conferences and festival known to locals as “South By.” But before the film and music festivals turn the energy “up to 11” in Austin, the interactive conference offers a platform for companies to showcase new technologies and discuss the impact of applied innovation.

Healthcare 52

Healthcare Healthcare Pharmacology Medicine 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales